MNPR stock

Monopar Therapeutics Inc (MNPR) earnings · $431.4M cap

These earnings events as JSON? API free 100/day

Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.

This MNPR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported MNPR revenue for 2025-12-31 was $0. Net income was -$13.7M. MNPR currently screens at market cap $431.4M.

When the next MNPR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

Period-over-period revenue change is not in cache for MNPR. We will not invent a beat or miss.

Not investment advice. Full MNPR research stays on the stock page; the tape stays on the quote page.

MNPR earnings FAQ

What is MNPR's latest net income?

Latest cached Monopar Therapeutics Inc (MNPR) net income was -$13.7M. Statements: https://lician.com/financials/mnpr

What is MNPR's latest basic EPS?

Latest cached Monopar Therapeutics Inc (MNPR) basic EPS for Dec 31, 2025 was -$1.85.

What period does the latest MNPR earnings print cover?

The latest cached Monopar Therapeutics Inc (MNPR) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.

Where are MNPR earnings listed?

Cached earnings facts for Monopar Therapeutics Inc (MNPR) are listed at https://lician.com/earnings/mnpr. Statements: https://lician.com/financials/mnpr

Not investment advice.

Full MNPR analysis